• Home
  • Resources
  • News
  • ACCC and Boston University Present the Project ECHO® Eight-Part Webinar Series, Powered by OncoLens

ACCC and Boston University Present the Project ECHO® Eight-Part Webinar Series, Powered by OncoLens

December 6, 2022

The Project ECHO® eight-part webinar series is powered by OncoLens, designed and managed by the Association of Community Cancer Centers (ACCC), accredited by Boston University Chobanian & Avedisian School of Medicine Barry M. Manuel Continuing Medical Education Office (BU_CME), and made possible by a grant from Bristol Myers Squibb (BMS).

Atlanta, GA: OncoLens–an innovator in multidisciplinary cancer care, and provider of a comprehensive, integrated treatment planning platform, was engaged by ACCC to power and disseminate via the OncoLens network, the Project ECHO® eight-part webinar series. The series kicked off with a Cardiology session on September 20, 2022, that exceeded attendance goals by 58%. A Gastroenterology session followed on October 18, 2022, with over 50% of the participants from the first session returning. Health care providers can register, at no charge, for the five remaining sessions—Rheumatology, Neurology, Hepatology, Dermatology, and Pulmonology.

Each session is designed to cover a different topic with Key Opinion Leaders discussing irAE monitoring and management strategies for approved cancer immunotherapies as well as for immunotherapies that have newly expanded indications for cancer treatment. During the session, health care participants,
from multiple disciplines, are welcome to submit unidentified clinical cases and will receive guidance from expert faculty. At the end of each session, participants will be able to:

  • Apply evidence-based practices for the monitoring and management of irAE in patients receiving cancer immunotherapies
  • Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAE in patients receiving cancer immunotherapies
  • Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies

“We are proud to support the Project ECHO® webinar series designed by ACCC and BU_CME,” said Anju Mathew, Chief Executive Officer of OncoLens. “This is another example of how partnerships across global nonprofits, leading medical education institutions, and innovators in multidisciplinary cancer treatment address health and community issues by providing care strategy education.”

###

About the Association of Community Cancer Centers (ACCC)

The Association of Community Cancer Centers (ACCC) is the leading education and advocacy organization for the cancer care community. Founded in 1974, ACCC is a powerful network of 30,000 multidisciplinary practitioners from 1,700 hospitals and practices nationwide. As advances in cancer screening and diagnosis, treatment options, and care delivery models continue to evolve – so has ACCC – adapting its resources to meet the changing needs of the entire oncology care team. For more information, visit accc-cancer.org.

Follow us on social media; read our blog, ACCCBuzz; tune in to our CANCER BUZZ podcast; and view our CANCER BUZZ TV channel.

About Boston University Chobanian & Avedisian School of Medicine, Barry M. Manuel Continuing Medical Education Office

Boston University Chobanian & Avedisian School of Medicine Continuing Medical Education designs, implements, and assesses evidence-based education for the healthcare team to advance their skills/strategies and performance, optimally leading to improved patient outcomes. We deliver activities in a wide variety of educational formats at the local, regional, and national level.

About Project ECHO®

Founded in 2003, Project ECHO® is a global nonprofit that empowers practitioners and professionals in rural and underserved areas to reduce disparities and improve the well-being of people in the communities where they live. ECHO’s free, virtual mentoring model addresses some of the world’s greatest challenges in health care, education and more, with a mission to touch 1 billion lives by 2025.

About OncoLens

OncoLens is the single platform that enables multidisciplinary cancer care across the continuum. Through a streamlined, secure HIPAA-compliant infrastructure, OncoLens drives intra-enterprise, community, network, and affiliate participation in multidisciplinary care planning, tracking, and delivery. The OncoLens platform allows providers to aggregate, create and track the comprehensive patient journey. This includes maximized clinical trial participation, an extended referral stream, and the creation of a center of excellence that can be leveraged to support patient care and provider education. More than 200 cancer centers and associations across the U.S and internationally rely on OncoLens to support their cancer programs and the care delivered.

Contact

OncoLens, info@oncolens.com

December 6, 2022
Follow Us